Main Session
Sep
28
PQA 04 - PQA 04: Breast Cancer, Patient Reported Outcomes/QoL/Survivorship, Nonmalignant Disease, Hematologic Malignancies, Palliative Care, and International/Global Oncology
2896 - Phase II Randomized Trial of Low-Dose Radiation Therapy plus Donanemab in Early Alzheimer's Disease: A Radiation-as-a-Drug Approach (RAD-CLEAR)
Presenter(s)
Evan Thomas, MD, PhD - Renaissance Institute for Precision Oncology & Radiosurgery , Winter Park , FL